BR112023022532A2 - Forma cristalina do derivado de tiofeno e método de preparação do mesmo - Google Patents

Forma cristalina do derivado de tiofeno e método de preparação do mesmo

Info

Publication number
BR112023022532A2
BR112023022532A2 BR112023022532A BR112023022532A BR112023022532A2 BR 112023022532 A2 BR112023022532 A2 BR 112023022532A2 BR 112023022532 A BR112023022532 A BR 112023022532A BR 112023022532 A BR112023022532 A BR 112023022532A BR 112023022532 A2 BR112023022532 A2 BR 112023022532A2
Authority
BR
Brazil
Prior art keywords
preparation
crystalline form
thiophene derivative
thiophene
derivative
Prior art date
Application number
BR112023022532A
Other languages
English (en)
Inventor
Wentao Wu
Wenyuan Zhu
Yang Zhang
Zhixiang Li
Original Assignee
Dongbao Purple Star Hangzhou Biopharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dongbao Purple Star Hangzhou Biopharmaceutical Co Ltd filed Critical Dongbao Purple Star Hangzhou Biopharmaceutical Co Ltd
Publication of BR112023022532A2 publication Critical patent/BR112023022532A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/72—Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

forma cristalina do derivado de tiofeno e método de preparação do mesmo. apresenta-se uma forma cristalina de um composto representado pela fórmula (i) e um método de preparação para o mesmo.
BR112023022532A 2021-04-29 2022-04-21 Forma cristalina do derivado de tiofeno e método de preparação do mesmo BR112023022532A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202110472705 2021-04-29
CN202111112439 2021-09-18
PCT/CN2022/088295 WO2022228280A1 (zh) 2021-04-29 2022-04-21 噻吩衍生物的晶型及其制备方法

Publications (1)

Publication Number Publication Date
BR112023022532A2 true BR112023022532A2 (pt) 2024-01-02

Family

ID=83847813

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023022532A BR112023022532A2 (pt) 2021-04-29 2022-04-21 Forma cristalina do derivado de tiofeno e método de preparação do mesmo

Country Status (8)

Country Link
EP (1) EP4332097A1 (pt)
JP (1) JP2024516222A (pt)
KR (1) KR20240004711A (pt)
CN (1) CN116867773A (pt)
AU (1) AU2022265937A1 (pt)
BR (1) BR112023022532A2 (pt)
CA (1) CA3216757A1 (pt)
WO (1) WO2022228280A1 (pt)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010044403A1 (ja) * 2008-10-15 2010-04-22 キッセイ薬品工業株式会社 ５員環ヘテロアリール誘導体及びその医薬用途
DK3344604T3 (da) * 2015-09-02 2020-12-07 Sunshine Lake Pharma Co Ltd Carboxy-substituerede (hetero) aromatiske ringderivater og fremstillingsfremgangsmåde og anvendelser deraf
MX2022004713A (es) * 2019-10-30 2022-05-11 Dongbao Purple Star Hangzhou Biopharmaceutical Co Ltd Derivados de tiofeno como inhibidores de xantina oxidasa y aplicacion de los mismos.

Also Published As

Publication number Publication date
JP2024516222A (ja) 2024-04-12
AU2022265937A1 (en) 2023-12-14
CN116867773A (zh) 2023-10-10
KR20240004711A (ko) 2024-01-11
WO2022228280A1 (zh) 2022-11-03
CA3216757A1 (en) 2022-11-03
EP4332097A1 (en) 2024-03-06

Similar Documents

Publication Publication Date Title
CY1121744T1 (el) Παραγωγα c4-μονομεθυλο-τριτερπενοειδους και μεθοδοι χρησης αυτων
CY1120080T1 (el) Φαρμακευτικη συνθεση περιεχουσα εναν αναστολεα hdac και εναν κυκλοπολυσακχαριτη
AR111304A1 (es) Métodos para sintetizar un inhibidor de mcl-1
CR20140301A (es) Derivados de betulina
EA201101026A1 (ru) Ингибиторы бета-секретазы
RS53292B (en) CRYSTAL FORMS 2-THIAZOLYL-4-HINOLINYL-OXY DERIVATIVES, POWERFUL HCV INHIBITOR
EA201990455A1 (ru) КОНДЕНСИРОВАННОЕ ТРИЦИКЛИЧЕСКОЕ ПРОИЗВОДНОЕ γ-АМИНОКИСЛОТЫ, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ЕГО МЕДИЦИНСКОЕ ПРИМЕНЕНИЕ
CY1124450T1 (el) Νουκλεοτιδια βητα-νικοτινικου εστερα και διεργασιες για την παρασκευη αυτων
EA202091269A1 (ru) Сульфон-, пиридин-, алкил-, амид-замещенные гетероарильные соединения
CY1123722T1 (el) Ενεσιμα φαρμακευτικα σκευασματα λεφαμουλινης
EA201991241A1 (ru) Способ получения метоксиметилпиридин дикарбоксилата
MX2020003020A (es) Compuestos de aminocarbonilcarbamato.
CL2020000376A1 (es) Compuesto pentacíclico.
AU2018316542A1 (en) Indole derivatives as histone demethylase inhibitors
MY185971A (en) Pyranodipyridine compound
WO2019023216A8 (en) INHIBITORS OF ROR GAMMA
EA202091979A1 (ru) Кристаллические формы и способы получения кристаллических форм соединения
CO2021014210A2 (es) Compuestos de pirrol
AR083412A1 (es) Composicion que controla las plagas y metodo para controlarlas
BR112021026556A2 (pt) Composto tricíclico, método de preparação para ele e uso dele
MX2021001904A (es) Formas solidas de benzoxaborol sustituido y composiciones de las mismas.
CL2022000802A1 (es) Compuestos heterocíclicos de arilmetileno como bloqueadores del canal shaker de potasio kv1.3
MX2021004386A (es) Compuestos novedosos.
MX2020004842A (es) Compuestos heterociclicos antiinfecciosos y sus usos.
BR112021026061A2 (pt) Método para o tratamento de uma composição que compreende vanilina natural